世界のヒトパラインフルエンザウイルス診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Human Parainfluenza Viruses Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2960 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、ヒトパラインフルエンザウイルス診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（HPV検査、フォローアップHPV検査、共同検査）、用途別市場規模（子宮頸がん検診、膣がん検診、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒトパラインフルエンザウイルス診断の市場動向 ・企業の競争状況、市場シェア ・ヒトパラインフルエンザウイルス診断の種類別市場規模（HPV検査、フォローアップHPV検査、共同検査） ・ヒトパラインフルエンザウイルス診断の用途別市場規模（子宮頸がん検診、膣がん検診、その他） ・ヒトパラインフルエンザウイルス診断の北米市場規模2016-2027（アメリカ、カナダ） ・ヒトパラインフルエンザウイルス診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒトパラインフルエンザウイルス診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒトパラインフルエンザウイルス診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒトパラインフルエンザウイルス診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Qiagen、Roche Diagnostics、Hologic、Abbott Laboratories、BD、Seegene） ・結論

Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.

Market Analysis and Insights: Global Human Parainfluenza Viruses Diagnostics Market
The global Human Parainfluenza Viruses Diagnostics market size is projected to reach US$ 935.8 million by 2026, from US$ 531.5 million in 2019, at a CAGR of 8.3% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Parainfluenza Viruses Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Parainfluenza Viruses Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Parainfluenza Viruses Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Parainfluenza Viruses Diagnostics market.

Global Human Parainfluenza Viruses Diagnostics Scope and Market Size
Human Parainfluenza Viruses Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Parainfluenza Viruses Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
HPV Testing
Follow-up HPV Testing
Co-testing

Segment by Application
Cervical Cancer Screening
Vaginal Cancer Screening
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Parainfluenza Viruses Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 HPV Testing
1.2.3 Follow-up HPV Testing
1.2.4 Co-testing
1.3 Market by Application
1.3.1 Global Human Parainfluenza Viruses Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cervical Cancer Screening
1.3.3 Vaginal Cancer Screening
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Human Parainfluenza Viruses Diagnostics Market Perspective (2016-2027)
2.2 Human Parainfluenza Viruses Diagnostics Growth Trends by Regions
2.2.1 Human Parainfluenza Viruses Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Parainfluenza Viruses Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Human Parainfluenza Viruses Diagnostics Industry Dynamic
2.3.1 Human Parainfluenza Viruses Diagnostics Market Trends
2.3.2 Human Parainfluenza Viruses Diagnostics Market Drivers
2.3.3 Human Parainfluenza Viruses Diagnostics Market Challenges
2.3.4 Human Parainfluenza Viruses Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Human Parainfluenza Viruses Diagnostics Players by Revenue
3.1.1 Global Top Human Parainfluenza Viruses Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Human Parainfluenza Viruses Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Parainfluenza Viruses Diagnostics Revenue
3.4 Global Human Parainfluenza Viruses Diagnostics Market Concentration Ratio
3.4.1 Global Human Parainfluenza Viruses Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Parainfluenza Viruses Diagnostics Revenue in 2020
3.5 Human Parainfluenza Viruses Diagnostics Key Players Head office and Area Served
3.6 Key Players Human Parainfluenza Viruses Diagnostics Product Solution and Service
3.7 Date of Enter into Human Parainfluenza Viruses Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Human Parainfluenza Viruses Diagnostics Breakdown Data by Type
4.1 Global Human Parainfluenza Viruses Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Type (2022-2027)

5 Human Parainfluenza Viruses Diagnostics Breakdown Data by Application
5.1 Global Human Parainfluenza Viruses Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Human Parainfluenza Viruses Diagnostics Market Size (2016-2027)
6.2 North America Human Parainfluenza Viruses Diagnostics Market Size by Type
6.2.1 North America Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2027)
6.3 North America Human Parainfluenza Viruses Diagnostics Market Size by Application
6.3.1 North America Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2027)
6.4 North America Human Parainfluenza Viruses Diagnostics Market Size by Country
6.4.1 North America Human Parainfluenza Viruses Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Human Parainfluenza Viruses Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Human Parainfluenza Viruses Diagnostics Market Size (2016-2027)
7.2 Europe Human Parainfluenza Viruses Diagnostics Market Size by Type
7.2.1 Europe Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2027)
7.3 Europe Human Parainfluenza Viruses Diagnostics Market Size by Application
7.3.1 Europe Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2027)
7.4 Europe Human Parainfluenza Viruses Diagnostics Market Size by Country
7.4.1 Europe Human Parainfluenza Viruses Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Human Parainfluenza Viruses Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Type
8.2.1 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Application
8.3.1 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Region
8.4.1 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Human Parainfluenza Viruses Diagnostics Market Size (2016-2027)
9.2 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Type
9.2.1 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Application
9.3.1 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Country
9.4.1 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Human Parainfluenza Viruses Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Type
10.2.1 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Application
10.3.1 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Country
10.4.1 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Qiagen
11.1.1 Qiagen Company Details
11.1.2 Qiagen Business Overview
11.1.3 Qiagen Human Parainfluenza Viruses Diagnostics Introduction
11.1.4 Qiagen Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
11.1.5 Qiagen Recent Development
11.2 Roche Diagnostics
11.2.1 Roche Diagnostics Company Details
11.2.2 Roche Diagnostics Business Overview
11.2.3 Roche Diagnostics Human Parainfluenza Viruses Diagnostics Introduction
11.2.4 Roche Diagnostics Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
11.2.5 Roche Diagnostics Recent Development
11.3 Hologic
11.3.1 Hologic Company Details
11.3.2 Hologic Business Overview
11.3.3 Hologic Human Parainfluenza Viruses Diagnostics Introduction
11.3.4 Hologic Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
11.3.5 Hologic Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Human Parainfluenza Viruses Diagnostics Introduction
11.4.4 Abbott Laboratories Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 BD
11.5.1 BD Company Details
11.5.2 BD Business Overview
11.5.3 BD Human Parainfluenza Viruses Diagnostics Introduction
11.5.4 BD Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
11.5.5 BD Recent Development
11.6 Seegene
11.6.1 Seegene Company Details
11.6.2 Seegene Business Overview
11.6.3 Seegene Human Parainfluenza Viruses Diagnostics Introduction
11.6.4 Seegene Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
11.6.5 Seegene Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Human Parainfluenza Viruses Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of HPV Testing
Table 3. Key Players of Follow-up HPV Testing
Table 4. Key Players of Co-testing
Table 5. Global Human Parainfluenza Viruses Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Parainfluenza Viruses Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Human Parainfluenza Viruses Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Human Parainfluenza Viruses Diagnostics Market Share by Regions (2016-2021)
Table 9. Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Human Parainfluenza Viruses Diagnostics Market Share by Regions (2022-2027)
Table 11. Human Parainfluenza Viruses Diagnostics Market Trends
Table 12. Human Parainfluenza Viruses Diagnostics Market Drivers
Table 13. Human Parainfluenza Viruses Diagnostics Market Challenges
Table 14. Human Parainfluenza Viruses Diagnostics Market Restraints
Table 15. Global Human Parainfluenza Viruses Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Human Parainfluenza Viruses Diagnostics Market Share by Players (2016-2021)
Table 17. Global Top Human Parainfluenza Viruses Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Parainfluenza Viruses Diagnostics as of 2020)
Table 18. Ranking of Global Top Human Parainfluenza Viruses Diagnostics Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Human Parainfluenza Viruses Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Parainfluenza Viruses Diagnostics Product Solution and Service
Table 22. Date of Enter into Human Parainfluenza Viruses Diagnostics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Type (2016-2021)
Table 26. Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Human Parainfluenza Viruses Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Application (2016-2021)
Table 30. Global Human Parainfluenza Viruses Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Human Parainfluenza Viruses Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Human Parainfluenza Viruses Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Human Parainfluenza Viruses Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Human Parainfluenza Viruses Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Human Parainfluenza Viruses Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Human Parainfluenza Viruses Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 62. Qiagen Company Details
Table 63. Qiagen Business Overview
Table 64. Qiagen Human Parainfluenza Viruses Diagnostics Product
Table 65. Qiagen Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021) & (US$ Million)
Table 66. Qiagen Recent Development
Table 67. Roche Diagnostics Company Details
Table 68. Roche Diagnostics Business Overview
Table 69. Roche Diagnostics Human Parainfluenza Viruses Diagnostics Product
Table 70. Roche Diagnostics Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021) & (US$ Million)
Table 71. Roche Diagnostics Recent Development
Table 72. Hologic Company Details
Table 73. Hologic Business Overview
Table 74. Hologic Human Parainfluenza Viruses Diagnostics Product
Table 75. Hologic Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021) & (US$ Million)
Table 76. Hologic Recent Development
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Human Parainfluenza Viruses Diagnostics Product
Table 80. Abbott Laboratories Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021) & (US$ Million)
Table 81. Abbott Laboratories Recent Development
Table 82. BD Company Details
Table 83. BD Business Overview
Table 84. BD Human Parainfluenza Viruses Diagnostics Product
Table 85. BD Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021) & (US$ Million)
Table 86. BD Recent Development
Table 87. Seegene Company Details
Table 88. Seegene Business Overview
Table 89. Seegene Human Parainfluenza Viruses Diagnostics Product
Table 90. Seegene Revenue in Human Parainfluenza Viruses Diagnostics Business (2016-2021) & (US$ Million)
Table 91. Seegene Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Parainfluenza Viruses Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. HPV Testing Features
Figure 3. Follow-up HPV Testing Features
Figure 4. Co-testing Features
Figure 5. Global Human Parainfluenza Viruses Diagnostics Market Share by Application: 2020 VS 2027
Figure 6. Cervical Cancer Screening Case Studies
Figure 7. Vaginal Cancer Screening Case Studies
Figure 8. Other Case Studies
Figure 9. Human Parainfluenza Viruses Diagnostics Report Years Considered
Figure 10. Global Human Parainfluenza Viruses Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Human Parainfluenza Viruses Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Human Parainfluenza Viruses Diagnostics Market Share by Regions: 2020 VS 2027
Figure 13. Global Human Parainfluenza Viruses Diagnostics Market Share by Regions (2022-2027)
Figure 14. Global Human Parainfluenza Viruses Diagnostics Market Share by Players in 2020
Figure 15. Global Top Human Parainfluenza Viruses Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Parainfluenza Viruses Diagnostics as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Human Parainfluenza Viruses Diagnostics Revenue in 2020
Figure 17. Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Type (2016-2021)
Figure 18. Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Type (2022-2027)
Figure 19. North America Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Human Parainfluenza Viruses Diagnostics Market Share by Type (2016-2027)
Figure 21. North America Human Parainfluenza Viruses Diagnostics Market Share by Application (2016-2027)
Figure 22. North America Human Parainfluenza Viruses Diagnostics Market Share by Country (2016-2027)
Figure 23. United States Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Human Parainfluenza Viruses Diagnostics Market Share by Type (2016-2027)
Figure 27. Europe Human Parainfluenza Viruses Diagnostics Market Share by Application (2016-2027)
Figure 28. Europe Human Parainfluenza Viruses Diagnostics Market Share by Country (2016-2027)
Figure 29. Germany Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Human Parainfluenza Viruses Diagnostics Market Share by Region (2016-2027)
Figure 39. China Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Human Parainfluenza Viruses Diagnostics Market Share by Type (2016-2027)
Figure 47. Latin America Human Parainfluenza Viruses Diagnostics Market Share by Application (2016-2027)
Figure 48. Latin America Human Parainfluenza Viruses Diagnostics Market Share by Country (2016-2027)
Figure 49. Mexico Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Human Parainfluenza Viruses Diagnostics Market Share by Country (2016-2027)
Figure 55. Turkey Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Human Parainfluenza Viruses Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Qiagen Revenue Growth Rate in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
Figure 59. Roche Diagnostics Revenue Growth Rate in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
Figure 60. Hologic Revenue Growth Rate in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
Figure 61. Abbott Laboratories Revenue Growth Rate in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
Figure 62. BD Revenue Growth Rate in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
Figure 63. Seegene Revenue Growth Rate in Human Parainfluenza Viruses Diagnostics Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

---